VEMLIDY is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Gilead Sciences, Inc.. The primary component is Tenofovir Alafenamide Fumarate.
| Product ID | 61958-2301_071939d1-7479-4b7c-bde2-eff9f1019017 |
| NDC | 61958-2301 |
| Product Type | Human Prescription Drug |
| Proprietary Name | VEMLIDY |
| Generic Name | Tenofovir Alafenamide |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2016-11-10 |
| Marketing Category | NDA / NDA |
| Application Number | NDA208464 |
| Labeler Name | Gilead Sciences, Inc. |
| Substance Name | TENOFOVIR ALAFENAMIDE FUMARATE |
| Active Ingredient Strength | 25 mg/1 |
| Pharm Classes | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2016-11-10 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA208464 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2016-11-10 |
| Ingredient | Strength |
|---|---|
| TENOFOVIR ALAFENAMIDE FUMARATE | 25 mg/1 |
| SPL SET ID: | 72e6b33c-0351-4070-9172-eeaa186c01d2 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() VEMLIDY 86765021 5001852 Live/Registered |
Gilead Sciences Ireland UC 2015-09-22 |